Indications & Uses
Used according to the active ingredient, diagnosis, product label and prescriber advice.
Bangladesh-focused generic medicine entry for pharmacy catalog search and product setup.
Used according to the active ingredient, diagnosis, product label and prescriber advice.
Add exact dosage instructions from approved product information.
Verify product details and regulatory registration before publishing for sale.
Tell your doctor or pharmacist about all current medicines, supplements and medical conditions before use.
Store according to product label instructions.
Side effects may vary by person. Stop use and consult a doctor if serious or unexpected symptoms occur.
Tablet
(30's pack: ৳ 450.00)
Bilastine
Use only as directed by physician or pharmacist.
Somatec Pharmaceuticals Ltd. · 20 mg
৳15General Pharmaceuticals Ltd. · 10 mg
৳15General Pharmaceuticals Ltd. · 20 mg
৳15Nuvista Pharma Ltd. · 20 mg
৳15Pacific Pharmaceuticals Ltd. · 20 mg
৳15Popular Pharmaceuticals Ltd. · 10 mg
৳15Popular Pharmaceuticals Ltd. · 20 mg
৳15Popular Pharmaceuticals Ltd. · 12.5 mg/5 ml
৳120The current price of Zilas 20 mg (20 mg Tablet, (30's pack: ৳ 450.00)) in Bangladesh is ৳15 (regular price ৳15). You can order genuine Zilas 20 mg online from MediZenix Pharmacy.
The active generic ingredient of Zilas 20 mg is Bilastine (20 mg). It is manufactured/supplied by Trusted supplier in Tablet form.
Used according to the active ingredient, diagnosis, product label and prescriber advice.
While Zilas 20 mg may not strictly require a prescription in the system, correct dosage depends on age, symptoms, and medical history. Always consult a doctor or pharmacist.
Yes, several brands in Bangladesh contain the same active ingredient (Bilastine). Always verify the exact strength (20 mg) and dosage form (Tablet) with a pharmacist before switching brands.
Store according to product label instructions.
Verified customer feedback and ratings.
No reviews yet. Be the first customer to review this item.
Ask a pharmacist/admin about this product.
No questions yet.